Information de reference pour ce titreAccession Number: | 00004725-200607000-00001.
|
Author: | Rabe, Jessica H. MD; Mamelak, Adam J. MD; McElgunn, Patrick J.S. MD; Morison, Warwick L. MD; Sauder, Daniel N. MD
|
Institution: | Department of Dermatology, Johns Hopkins University, Baltimore, Maryland
|
Title: | |
Source: | Journal of the American Academy of Dermatology. 55(1):1-19, July 2006.
|
Abstract: | Aging is a complex, multifactorial process resulting in several functional and esthetic changes in the skin. These changes result from intrinsic as well as extrinsic processes, such as ultraviolet radiation. Recent advances in skin biology have increased our understanding of skin homeostasis and the aging process, as well as the mechanisms by which ultraviolet radiation contributes to photoaging and cutaneous disease. These advances in skin biology have led to the development of a diversity of treatments aimed at preventing aging and rejuvenating the skin. The focus of this review is the mechanism of photoaging and the pathophysiology underlying the treatments specifically designed for its prevention and treatment.
Learning objectives: At the conclusion of this learning activity, participants should be familiar with the mechanism of photoaging, the treatments for photoaging, and the data that supports the use of these treatments.
(C) 2006 by Mosby, Inc.
|
References: | 1. Encyclopedia Britannica Premium Service. Aging. Encyclopedia Britannica. Accessed August 10, 2004.
2. Kligman AM, Graham JA. The psychology of appearance in the elderly. Clin Geriatr Med 1989;5:213-222.
3. Gonzalez-Ulloa M, Flores ES. Senility of the face-basic study to understand its causes and effects. Plast Reconstr Surg 1965;36:239-246.
4. Lavker RM, Zheng P, Dong G. Morphology of aged skin. Clin Geriatr Med 1989;5:53-67.
5. Kligman L. Photoaging: manifestations, prevention, and treatment. Clin Geriatr Med 1989;5:235-251.
6. Yaar M, Gilchrest BA. Aging of skin. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz S, eds. Fitzpatrick's dermatology in general medicine. New York: McGraw-Hill; 2003. p. 1386-1398.
7. Vaziri H, Benchimol S. From telomere loss to p53 induction and activation of a DNA-damage pathway at senescence: the telomere loss/DNA damage model of cell aging. Exp Gerontol 1996;31:295-301.
8. Campisi J. Replicative senescence: an old lives' tale? Cell 1996;84:497-500.
9. Yasui H, Sakurai H. Age-dependent generation of reactive oxygen species in the skin of live hairless rats exposed to UVA light. Exp Dermatol 2003;12:655-661.
10. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956;11:298-300.
11. Tolmasoff JM, Ono T, Cutler RG. Superoxide dismutase: correlation with life-span and specific metabolic rate in primate species. Proc Natl Acad Sci U S A 1980;77:2777-2781.
12. Hoppe U, Bergemann J, Diembeck W, Ennen J, Gohla S, Harris I, et al. Coenzyme Q10, a cutaneous antioxidant and energizer. BioFactors 1999;9:371-378.
13. Kosmadaki MG, Gilchrest BA. The role of telomeres in skin aging/photoaging. Micron 2004;35:155-159.
14. Chu DH, Haake AR, Holbrook K, Loomis CA. The structure and development of skin. In: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz S, eds. Fitzpatrick's dermatology in general medicine, New York: McGraw-Hill; 2003. p. 58-88.
15. Stanulis-Praeger BM, Gilchrest BA. Growth factor responsiveness declines during adulthood for human skin-derived cells. Mech Ageing Dev 1986;35:185-198.
16. Reenstra WR, Yaar M, Gilchrest BA. Aging affects epidermal growth factor receptor phosphorylation and traffic kinetics. Exp Cell Res 1996;227:252-255.
17. Elias PM, Ghadially R. The aged epidermal permeability barrier: basis for functional abnormalities. Clin Geriatr Med 2002;18:103-120.
18. Yaar M, Gilchrest BA. Ageing and photoageing of keratinocytes and melanocytes. Clin Exp Dermatol 2001;26:583-591.
19. Bergstresser PR, Costner MI. Anatomy and physiology. In: Bolognia J, Jorizzo J, Rapini R, eds. Dermatology. St Louis: Mosby; 2003. p. 25-38.
20. Gilchrest BA, Blog FB, Szabo G. Effects of aging and chronic sun exposure on melanocytes in human skin. J Invest Dermatol 1979;73:141-143.
21. Sunderkotter C, Kalden H, Luger T. Aging and the skin immune system. Arch Dermatol 1997;133:1256-1262.
22. Sauder DN. Effect of age on epidermal immune function. Clin Geriatr Med 1989;5:149-160.
23. Edwards DR, Leco KJ, Beaudry PP, Atadja PW, Veillette C, Riabowol KT. Differential effects of transforming growth factor-beta 1 on the expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in young and old human fibroblasts. Exp Gerontol 1996;31:207-223.
24. Uitto J, Fazio MJ, Olsen DR. Molecular mechanisms of cutaneous aging: age associated connective tissue alterations in the dermis. J Am Acad Dermatol 1989;21:614-622.
25. Bentley JP. Aging of collagen. J Invest Dermatol 1979;73:80-83.
26. Varadi DP. Studies on the chemistry and fine structure of elastic fibers from normal adult skin. J Invest Dermatol 1972;59:238-246.
27. Lewis KG, Bercovitch L, Dill SW, Robinson-Bostom L. Acquired disorders of elastic tissue: part I. Increased elastic tissue and solar elastotic syndromes. J Am Acad Dermatol 2004;51:1-21.
28. Hornebeck W. Down-regulation of tissue inhibitor of matrix metalloprotease-1 (TIMP-1) in aged human skin contributes to matrix degradation and impaired cell growth and survival. Pathol Biol 2003;51:569-573.
29. Hughes VA, Roubenoff R, Wood M, Frontera WR, Evans WJ, Fiatarone Singh MA. Anthropometric assessment of 10-y changes in body composition in the elderly. Am J Clin Nutr 2004;80:475-482.
30. Wong G, Gupta R, Dixon KM, Deo SS, Choong SM, Halliday GM, et al. 1,25-Dihydroxyvitamin D and three low-calcemic analogs decrease UV-induced DNA damage via the rapid response pathway. J Steroid Biochem Mol Biol 2004;89-90:567-570.
31. MacLaughlin J, Holick MF. Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 1985;76:1536-1538.
32. Brincat MP. Hormone replacement therapy and the skin. Maturitas 2000;29:107-117.
33. Dunn LB, Damesyn M, Moore A, Reuben DB, Greendale GA. Does estrogen prevent skin aging? Arch Dermatol 1997;133:339-342.
34. Ashcroft GS, Dodsworth J, Van Boxtel E, Tarnuzzer RW, Horan MA, Schultz GS, et al. Estrogen accelerates cutaneous wound healing associated with an increase in TGF-beta1 levels. Nat Med 1997;3:1209-1215.
35. Besne I, Descombes C, Breton L. Effect of age and anatomical site on density of sensory innervation in human epidermis. Arch Dermatol 2002;138:1445-1450.
36. Young AJ. Effects of aging on human cold tolerance. Exp Aging Res 1991;17:205-213.
37. Gosain A, DiPietro LA. Aging and wound healing. World J Surg 2004;28:321-326.
38. Goukassian D, Gad F, Yaar M, Eller M, Nehal U, Gilchrest B. Mechanisms and implications of the age-associated decrease in DNA repair capacity. FASEB J 2000;14:1325-1334.
39. Francis MK, Appel S, Meyer C, Balin SJ, Balin AK, Cristofalo VJ. Loss of EPC-1/PEDF expression during skin aging in vivo. J Invest Dermatol 2004;122:1096-1105.
40. Kligman A, Kligman L. Photoaging. In: Freedberg IM, Eisen AZ, Wolff K, Austen F, Goldsmith LA, Katz SI, et al, eds. Fitzpatrick's dermatology in general medicine. New York: McGraw-Hill; 1999. p. 1717-1723.
41. Wlaschek M, Tantcheva-Poor I, Naderi L, Ma W, Schneider LA, Razi-Wolf Z, et al. Solar UV irradiation and dermal photoaging. J Photochem Photobiol B 2001;63:41-51.
42. Gilchrest BA, Yaar M. Ageing and photoageing of the skin: observations at the cellular and molecular level. Br J Dermatol 1992;127:25-30.
43. Leyden JJ. Clinical features of aging skin. Br J Dermatol 1990;122:1-3.
44. Lavker RM. Cutaneous aging: chronologic versus photoaging. In: Gilchrest BA, eds. Photodamage. Cambridge: Blackwell Science; 1995. p. 123-135.
45. Yeatman JM, Kilkenny M, Marks R. The prevalence of seborrhoeic keratoses in an Australian population: does exposure to sunlight play a part in their frequency? Br J Dermatol 1997;137:411-414.
46. Gilchrest BA. A review of skin ageing and its medical therapy. Br J Dermatol 1996;135:867-875.
47. El Domyati M, Attia S, Saleh F, Brown D, Birk DE, Gasparro F, et al. Intrinsic aging vs. photoaging: a comparative histopathological, immunohistochemical, and ultrastructural study of skin. Exp Dermatol 2002;11:398-405.
48. Lavker RM, Kligman AM. Chronic heliodermatitis: a morphologic evaluation of chronic actinic damage with emphasis on the role of mast cells. J Invest Dermatol 1988;90:325-330.
49. Varani J, Schuger L, Dame MK, Leonard C, Fligiel SEG, Kang S, et al. Reduced fibroblast interaction with intact collagen as a mechanism for depressed collagen synthesis in photodamaged skin. J Invest Dermatol 2004;122:1471-1479.
50. Varani J, Spearman D, Perone P, Fligiel SEG, Datta SC, Wang ZQ, et al. Inhibition of type I procollagen synthesis by damaged collagen in photoaged skin and by collagenase-degraded collagen in vitro. Am J Pathol 2001;158:931-942.
51. Bernstein EF, Brown D, Urbach F, Forbes D, DelMonaco M, Wu M, et al. Ultraviolet radiation activates the human elastin promoter in transgenic mice: a novel in vivo and in vitro model of cutaneous photoaging. J Invest Dermatol 1995;105:269-273.
52. Kligman AM, Zheng P, Lavker RM. The anatomy and pathogenesis of wrinkles. Br J Dermatol 1985;113:37-42.
53. Bernstein EF, Brown DB, Schwartz MD, Kaidbey K, Ksenzenko SM. The polyhydroxy acid gluconolactone protects against ultraviolet radiation in an in vitro model of cutaneous photoaging. Dermatol Surg 2004;30:189-196.
54. Kochevar IE. Molecular and cellular effects of UV radiation relevant to chronic photodamage. In: Gilchrest BA, eds. Photodamage. Cambridge: Blackwell Science; 1995. p. 51-67.
55. Tornaletti S, Pfeifer GP. UV damage and repair mechanisms in mammalian cells. BioEssays 1996;18:221-228.
56. Linge C. Relevance of in vitro melanocytic cell studies to the understanding of melanoma. Cancer Surv 1996;26:71-87.
57. Ichihashi M, Ueda M, Budiyanto A, Bito T, Oka M, Fukunaga M, et al. UV-induced skin damage. Toxicology 2003;189:21-39.
58. Mitchell DL, Jen J, Cleaver JE. Relative induction of cyclobutane dimers and cytosine photohydrates in DNA irradiated in vitro and in vivo with ultraviolet-C and ultraviolet-B light. Photochem Photobiol 1991;54:741-746.
59. Bissett DL, Hannon DP, Orr TV. Wavelength dependence of histological, physical, and visible changes in chronically UV-irradiated hairless mouse skin. Photochem Photobiol 1989;50:763-769.
60. Kligman L, Sayre RM. An action spectrum for ultraviolet induced elastosis in hairless mice: quantification of elastosis by image analysis. Photochem Photobiol 1991;53:237-242.
61. Cadet J, Douki T, Pouget J.-P., Ravanat J.-L. Singlet oxygen DNA damage products: formation and measurement. Methods Enzymol 2000;319:143-153.
62. Fisher GJ, Kang S, Varani J, Bata-Csorgo Z, Wan Y, Datta S, et al. Mechanisms of photoaging and chronological skin aging. Arch Dermatol 2002;138:1462-1470.
63. Berlett BS, Stadtman ER. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 1997;272:20313-20316.
64. de Gruijl FR. Photocarcinogenesis: UVA vs UVB. Methods Enzymol 2000;319:359-366.
65. Hanson K, Simon J. Epidermal trans-urocanic acid and the UV-A-induced photoaging of the skin. Proc Natl Acad Sci U S A 1998;96:10576-10578.
66. Menon EL, Morrison H. Formation of singlet oxygen by urocanic acid by UVA irradiation and some consequences thereof. Photochem Photobiol 2002;75:565-569.
67. Berneburg M, Grether-Beck S, Kurten V, Ruzicka T, Briviba K, Sies H, et al. Singlet oxygen mediates the UVA-induced generation of the photoaging-associated mitochondrial common deletion. J Biol Chem 1999;274:15345-15349.
68. Berneburg M, Plettenberg H, Medve-Konig K, Pfahlberg A, Gers-Barlag H, Gefeller O, et al. Induction of the photoaging-associated mitochondrial common deletion in vivo in normal human skin. J Invest Dermatol 2004;122:1277-1283.
69. Birch-Machin MA, Tindall M, Turner R, Haldane F, Rees JL. Mitochondrial DNA deletions in human skin reflect photo- rather than chronologic aging. J Invest Dermatol 1998;110:149-152.
70. Krutmann J. Ultraviolet A radiation-induced biological effects in human skin: relevance for photoaging and photodermatosis. J Dermatol Sci 2000;23(Suppl):S22-S26.
71. Mamelak AJ, Kowalski J, Murphy K, Yadava N, Zahurak M, Kouba DJ, et al. Downregulation of NDUFA1 and other oxidative phosphorylation related genes is a consistent feature of basal cell carcinoma. Exp Dermatol 2005;14:336-348.
72. Soter NA. Sunburn and suntan: immediate manifestations of photodamage. In: Gilchrest BA, eds. Photodamage. Cambridge (MA): Blackwell Science; 1995. p. 12-25.
73. Halaban R, Hebert DN, Fisher GJ. Biology of melanocytes. In: Freedberg IM, Eisen AZ, Wolff K, Austen F, Goldsmith LA, Katz SI, eds. Fitzpatrick's dermatology in general medicine. New York: McGraw-Hill; 2003. p. 127-148.
74. Braun-Falco O, Schoefinius HH. Lentigo senilis. Hautarzt 1971;22:277-283.
75. Hodgson C. Lentigo senilis. Arch Dermatol 1963;87:197-207.
76. Montagna W, Hu F, Carlisle K. A reinvestigation of solar lentigines. Arch Dermatol 1980;116:1151-1154.
77. Ortonne J.-P., Perrot H. Idiopathic guttate hypomelanosis. Ultrastructural study. Arch Dermatol 1980;116:664-668.
78. Wilson PD, Lavker RM, Kligman AM. On the nature of idiopathic guttate hypomelanosis. Acta Derm Venerol 1982;62:301-306.
79. Abeyama K, Eng W, Jester JV, Vink AA, Edelbaum D, Cockerell CJ, et al. A role for NF-[kappa]B-dependent gene transactivation in sunburn. J Clin Invest 2000;105:1751-1759.
80. Kosmadaki MG, Yaar M, Arble BL, Gilchrest BA. UV induces VEGF through a TNF-alpha independent pathway. FASEB J 2003;17:446-448.
81. Yano K, Kajiya K, Ishiwata M, Hong YK, Miyakawa T, Detmar M. Ultraviolet B-induced skin angiogenesis is associated with a switch in the balance of vascular endothelial growth factor and thrombospondin-1 expression. J Invest Dermatol 2004;122:201-208.
82. Howell BG, Wang B, Freed I, Mamelak AJ, Watanabe H, Sauder DN. Microarray analysis of UVB-regulated genes in keratinocytes: downregulation of angiogenesis inhibitor thrombospondin-1. J Dermatol Sci 2004;34:185-194.
83. Aubin F. Mechanisms involved in ultraviolet light-induced immunosuppression. Eur J Dermatol 2003;13:515-523.
84. Kripke ML. Immunology and photocarcinogenesis: new light on an old problem. J Am Acad Dermatol 1986;14:149-155.
85. Toews GB, Bergstresser P, Streilein JW. Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB. J Immunol 1980;124:445-453.
86. Noonan FP, Kripke ML, Pedersen GM, Greene MI. Suppression of contact hypersensitivity in mice by ultraviolet irradiation is associated with defective antigen presentation. Immunology 1981;43:527-533.
87. Molendijk A, van Gurp RJ, Donselaar IG, Benner R. Suppression of delayed-type hypersensitivity to histocompatibility antigens by ultraviolet radiation. Immunology 1987;62:299-305.
88. Vink AA, Moodycliffe AM, Shreedhar V, Ullrich SE, Roza L, Yarosh DB, et al. The inhibition of antigen-presenting activity of dendritic cells resulting from UV irradiation of murine skin is restored by in vitro photorepair of cyclobutane pyrimidine dimers. Proc Natl Acad Sci U S A 1997;94:5255-5260.
89. Kang K, Hammerberg C, Meunier L, Cooper KD. CD11b+ macrophages that infiltrate human epidermis after in vivo ultraviolet exposure potently produce IL-10 and represent the major secretory source of epidermal IL-10 protein. J Immunol 1994;153:5256-5264.
90. Weiss E, Mamelak AJ, La Morgia S, Wang B, Feliciani C, Tulli A, et al. The role of interleukin 10 in the pathogenesis and potential treatment of skin diseases. J Am Acad Dermatol 2004;50:657-675.
91. Heck DE, Gerecke DR, Vetrano AM, Laskin JD. Solar ultraviolet radiation as a trigger of cell signal transduction. Toxicol Appl Pharmacol 2004;195:288-297.
92. Gross S, Knebel A, Tenev T, Neininger A, Gaestel M, Herrlich P, et al. Inactivation of protein-tyrosine phosphatases as mechanism of UV-induced signal transduction. J Biol Chem 1999;274:26378-26386.
93. Barford D, Jia Z, Tonks NK. Protein tyrosine phosphatases take off. Nat Struct Biol 1995;2:1043-1053.
94. Fisher GJ, Talwar HS, Lin J, Lin P, McPhillips F, Wang Z, et al. Retinoic acid inhibits induction of c-jun protein by ultraviolet radiation that occurs subsequent to activation of mitogen-activated protein kinase pathways in human skin in vivo. J Clin Invest 1998;101:1432-1440.
95. Fisher GJ, Wang Z, Datta SC, Varani J, Kang S, Voorhees JJ. Pathophysiology of premature skin aging induced by ultraviolet light. N Engl J Med 1997;337:1419-1429.
96. Polte T, Tyrrell RM. Involvement of lipid peroxidation and organic peroxides in UVA-induced matrix metalloproteinase-1 expression. Free Radic Biol Med 2004;36:1566-1574.
97. Brennan M, Bhatti H, Nerusu KC, Bhagavathula N, Kang S, Fisher GJ, et al. Matrix metalloproteinase-1 is the major collagenolytic enzyme responsible for collagen damage in UV-irradiated human skin. Photochem Photobiol 2003;78:43-48.
98. Reelfs O, Tyrrell RM, Pourzand C. Ultraviolet A radiation-induced immediate iron release is a key modulator of the activation of NF-[kappa]B in human skin fibroblasts. J Invest Dermatol 2004;122:1440-1447.
99. Kang S, Fisher GJ, Voorhees JJ. Photoaging: pathogenesis, prevention, and treatment. Clin Geriatr Med 2001;17:643-659.
100. Fisher GJ, Datta S, Talwar HS, Wang Z, Varani J, Voorhees JJ. Molecular basis of sun-induced premature skin ageing and retinoid antagonism. Nature 1996;379:335-339.
101. Talwar HS, Griffiths CEM, Fisher GJ, Hamilton TA, Voorhees JJ. Reduced type I and type III procollagens in photodamaged adult human skin. J Invest Dermatol 1995;105:285-290.
102. Fisher GJ, Datta S, Wang Z, Li XY, Quan T, Chung JH, et al. c-Jun-dependent inhibition of cutaneous procollagen transcription following ultraviolet irradiation is reversed by all-trans retinoic acid. J Clin Invest 2000;106:663-670.
103. Quan T, He T, Kang S, Voorhees JJ, Fisher GJ. Ultraviolet irradiation alters transforming growth factor beta/smad pathway in human skin in vivo. J Invest Dermatol 2002;119:499-506.
104. Penttinen RP, Kobayashi S, Bornstein P. Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. Proc Natl Acad Sci U S A 1988;85:1105-1108.
105. Chung KY, Agarwal A, Uitto J, Mauviel A. An AP-1 binding sequence is essential for regulation of the human alpha2(I) collagen (COL1A2) promoter activity by transforming growth factor-beta. J Biol Chem 1996;271:3272-3278.
106. Varani J, Perone P, Fligiel SEG, Fisher GJ, Voorhees JJ. Inhibition of type I procollagen production in photodamage: correlation between presence of high molecular weight collagen fragments and reduced procollagen synthesis. J Invest Dermatol 2002;119:122-129.
107. Fligiel SEG, Varani J, Datta SC, Kang S, Fisher GJ, Voorhees JJ. Collagen degradation in aged/photodamaged skin in vivo and after exposure to matrix metalloproteinase-1 in vitro. J Invest Dermatol 2003;120:842-848.
108. Nagpal S, Chandraratna RAS. Recent developments in receptor-selective retinoids. Curr Pharm Des 2000;6:919-931.
109. Nagpal S, Athanikar J, Chandraratna RAS. Separation of transactivation and AP1 antagonism functions of retinoic acid receptor alpha. J Biol Chem 1995;270:923-927.
110. Wang Z, Boudjelal M, Kang S, Voorhees JJ, Fisher GJ. Ultraviolet irradiation of human skin causes functional vitamin A deficiency, preventable by all-trans retinoic acid pre-treatment. Nat Med 1999;5:418-422.
111. Andersson E, Rosdahl I, Torma H, Vahlquist A. Differential effects of UV irradiation on nuclear retinoid receptor levels in cultured keratinocytes and melanocytes. Exp Dermatol 2003;12:563-571.
112. Berne B, Nilsson M, Vahlquist A. UV irradiation and cutaneous vitamin A. An experimental study in rabbit and human skin. J Invest Dermatol 1984;83:401-404.
113. Rijken F, Bruijnzeel PLB, van Weelden H, Kiekens RCM. Responses of black and white skin to solar-simulating radiation: differences in DNA photodamage, infiltrating neutrophils, proteolytic enzymes induced, keratinocyte activation, and IL-10 expression. J Invest Dermatol 2004;122:1448-1455.
114. Matsumura Y, Ananthaswamy HN. Toxic effects of ultraviolet radiation on the skin. Toxicol Appl Pharmacol 2004;195:298-308.
115. Shindo Y, Witt E, Han D, Epstein W, Packer L. Enzymic and non-enzymic antioxidants in epidermis and dermis of human skin. J Invest Dermatol 1994;102:122-124.
116. Epstein JH. Effects of ultraviolet radiation on the mitotic cycle and DNA, RNA and protein synthesis in mammalian epidermis in vivo. Photochem Photobiol 1970;12:57-65.
117. Everett MA. Protection from sunlight in vitiligo. Arch Dermatol 1961;84:997-998.
118. Szabo G. Pigment cell biology. In: Gordon M, eds. Mitochondria and other cytoplasmic inclusions. New York: Academic Press; 1959.
119. Kaidbey K, Agin PP, Sayre RM, Kligman AM. Photoprotection by melanin-a comparison of black and Caucasian skin. J Am Acad Dermatol 1979;1:249-260.
120. Huang LC, Clarkin KC, Wahl GM. Sensitivity and selectivity of the DNA damage sensor responsible for activating p53-dependent G1 arrest. Proc Natl Acad Sci U S A 1996;93:4827-4832.
121. Cleaver JE, Cortes F, Karentz D, Lutze L, Morgan WF, Player AN, et al. The relative importance of cyclobutane and (6-4) pyrimidine-pyrimidone dimer photoproducts in human cells: evidence from a xeroderma pigmentosum revertant. Photochem Photobiol 1988;48:41-49.
122. Young LC, Hays JB, Tron VA, Andrew SE. DNA mismatch repair proteins: potential guardians against genomic instability and tumorigenesis induced by ultraviolet photoproducts. J Invest Dermatol 2003;121:435-440.
123. Oh JH, Chung AS, Steinbrenner H, Sies H, Brenneisen P. Thioredoxin secreted upon ultraviolet A irradiation modulates activities of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in human dermal fibroblasts. Arch Biochem Biophys 2004;423:218-226.
124. Hata TR, Scholz TA, Ermakov IV, McClane RW, Khachik F, Gellermann W, et al. Non-invasive raman spectroscopic detection of carotenoids in human skin. J Invest Dermatol 2000;115:441-448.
125. Leccia MT, Yaar M, Allen N, Gleason M, Gilchrest BA. Solar simulated irradiation modulates gene expression and activity of antioxidant enzymes in cultured human dermal fibroblasts. Exp Dermatol 2001;10:272-279.
126. Fuchs J. Potentials and limitations of the natural antioxidants RRR-alpha-tocopherol, L-ascorbic acid and beta-carotene in cutaneous photoprotection. Free Radic Biol Med 1998;25:848-873.
127. Shindo Y, Hashimoto T. Time course of changes in antioxidant enzymes in human skin fibroblasts after UVA irradiation. J Dermatol Sci 1997;14:225-232.
128. Matzen RN. Preventive medicine: definition and application. In: Lang RS, Hensrud DD, editors. Clinical preventive medicine. AMA Press; 2004. pp. 3-9.
129. Guyatt GH, Sackett DL, Sinclair JC, Hayward R, Cook D, Cook RJ. User's guide to the medical literature IX. A method for grading health care recommendations. JAMA 1995;274:1800-1804.
130. Cochrane Reviewers' Handbook 2.2.2. [updated March 2004] The Cochrane Library, Issue 1, 2004. Chichester (UK): John Wiley and Sons Ltd; 2004.
131. Weiss JS, Ellis CN, Headington JT, Tincoff T, Hamilton TA, Voorhees JJ. Topical tretinoin improves photodamaged skin: a double-blind, vehicle-controlled study. JAMA 1988;259:527-532.
132. Weinstein GD, Nigra TP, Pochi PE, Savin RC, Allan A, Benik K, et al. Topical tretinoin for treatment of photodamaged skin. A multicenter study. Arch Dermatol 1991;127:659-665.
133. Kang S, Leyden JJ, Lowe NJ, Ortonne JP, Phillips TJ, Weinstein GD, et al. Tazarotene cream for the treatment of facial photodamage: a multicenter, investigator-masked, randomized, vehicle-controlled, parallel comparison of 0.01%, 0.025%, 0.05%, and 0.1% tazarotene creams with 0.05% tretinoin emollient cream applied once daily for 24 weeks. Arch Dermatol 2001;137:1597-1604.
134. Phillips TJ, Gottlieb AB, Leyden JJ, Lowe NJ, Lew-Kaya DA, Sefton J, et al. Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial. Arch Dermatol 2002;138:1486-1493.
135. Humbert PG, Haftek M, Creidi P, Lapiere C, Nusgens B, Richard A, et al. Topical ascorbic acid on photoaged skin. Clinical, topographical and ultrastructural evaluation: double-blind study vs. placebo. Exp Dermatol 2003;12:237-244.
136. Murad H, Tabibian MP. The effect of an oral supplement containing glucosamine, amino acids, minerals, and antioxidants on cutaneous aging: a preliminary study. J Dermatolog Treat 2001;12:47-51.
137. Greul AK, Grundmann JU, Heinrich F, Pfitzner I, Bernhardt J, Ambach A, et al. Photoprotection of UV-irradiated human skin: an antioxidative combination of vitamins E and C, carotenoids, selenium and proanthocyanidins. Skin Pharmacol Appl Skin Physiol 2002;15:307-315.
138. Beitner H. Randomized, placebo-controlled, double blind study on the clinical efficacy of a cream containing 5% alpha-lipoic acid related to photoageing of facial skin. Br J Dermatol 2003;149:841-849.
139. Sauerbronn AVD, Fonseca AM, Bagnoli VR, Saldiva PH, Pinotti JA. The effects of systemic hormonal replacement therapy on the skin of postmenopausal women. Int J Gynaecol Obstet 2000;68:35-41.
140. Brincat MP, Versi E, O'Dowd T, Moniz CF, Magos A, Kabalan S, et al. Skin collagen changes in post menopausal women receiving oestradiol gel. Maturitas 1987;9:1-5.
141. Schmidt JB, Binder M, Demschik G, Bieglmayer C, Reiner A. Treatment of skin aging with topical estrogens. Int J Dermatol 1996;35:669-674.
142. Fitzpatrick RE, Rostan EF. Reversal of photodamage with topical growth factors: a pilot study. J Cosmet Laser Ther 2003;5:25-34.
143. Robert C, Robert AM, Robert L. Effect of a fucose-rich polysaccharide preparation on the age-dependent evolution of the skin surface micro-relief. Pathol Biol 2003;51:586-590.
144. Bauza E, Dal Farra C, Berghi A, Oberto G, Peyronel D, Domloge N. Date palm kernel extract exhibits antiaging properties and significantly reduces skin wrinkles. Int J Tissue React 2002;24:131-136.
145. Newman N, Newman A, Moy LS, Babapour R, Harris AG, Moy RL. Clinical improvement of photoaged skin with 50% glycolic acid: a double-blind vehicle-controlled study. Dermatol Surg 1996;22:455-460.
146. Freedman BM, Rueda-Pedraza E, Waddell SP. The epidermal and dermal changes associated with microdermabrasion. Dermatol Surg 2001;27:1031-1034.
147. Abraham MT, Keller GS, Pinkosky G, Feibleman CE, Kelly J, Man D, et al. Microcoblation: nonablative skin rejuvenation. Facial Plast Surg 2004;20:51-56.
148. Weiss RA, Harrington AC, Pfau RC, Weiss MA, Marwaha S. Periorbital skin resurfacing using high energy erbium:YAG laser: results in 50 patients. Lasers Surg Med 1999;24:81-86.
149. Tanzi EL, Williams CM, Alster TS. Treatment of facial rhytides with a nonablative 1,450-nm diode laser: a controlled clinical and histologic study. Dermatol Surg 2003;29:124-128.
150. Alster TS, Tanzi E. Improvement of neck and cheek laxity with a nonablative radiofrequency device: a lifting experience. Dermatol Surg 2004;30:503-507.
151. Carruthers JA, Lowe NJ, Menter MA, Gibson J, Nordquist M, Mordaunt J, et al. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines. J Am Acad Dermatol 2002;46:840-849.
152. Baumann L, Slezinger A, Vujevich J, Halem M, Bryde J, Black L, et al. A double-blinded, randomized, placebo-controlled pilot study of the safety and efficacy of Myobloc (botulinum toxin type B)-purified neurotoxin complex for the treatment of crow's feet: a double-blinded, placebo-controlled trial. Dermatol Surg 2003;29:508-515.
153. Narins RS, Brandt F, Leyden J, Lorenc ZP, Rubin M, Smith S. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003;29:588-595.
154. Sclafani AP, Romo T 3rd, Jacono AA, McCormick S, Cocker R, Parker A. Evaluation of acellular dermal graft in sheet (AlloDerm) and injectable (Micronized AlloDerm) forms for soft tissue augmentation: clinical observations and histological analysis. Arch Facial Plast Surg 2000;2:130-136.
155. Sclafani AP, Romo T 3rd, Jacono AA, McCormick SA, Cocker R, Parker A. Evaluation of acellular dermal graft (AlloDerm) sheet for soft tissue augmentation: a 1-year follow-up of clinical observations and histological findings. Arch Facial Plast Surg 2001;3:101-103.
156. Glaser DA. Anti-aging products and cosmeceuticals. Facial Plast Surg Clin North Am 2003;11:219-227.
157. Morison WL. Photoprotection by clothing. Dermatol Ther 2003;16:16-22.
158. Diffey BL. Sun protection with clothing. Br J Dermatol 2001;144:449-451.
159. Seite S, Colige A, Piquemal-Vivenot P, Montastier C, Fourtanier A, Lapiere C, et al. A full-UV spectrum absorbing daily use cream protects human skin against biological changes occurring in photoaging. Photodermatol Photoimmunol Photomed 2000;16:147-155.
160. Naylor M, Gasparro F. What you and your patients should know about sunscreens. Skin Aging 1998;6:44-50.
161. Pinnell SR, Fairhurst D, Gillies R, Mitchnick MA, Kollias N. Microfine zinc oxide is a superior sunscreen ingredient to microfine titanium dioxide. Dermatol Surg 2000;26:309-314.
162. Food and Drug Administration Final Sunscreen Monograph. 64 Federal Register (98):27691-27692. May 21, 1999.
163. Haywood R, Wardman P, Sanders R, Linge C. Sunscreens inadequately protect against ultraviolet-A-induced free radicals in skin: implications for skin aging and melanoma? J Invest Dermatol 2003;121:862-868.
164. Takeuchi T, Uitto J, Bernstein EF. A novel in vivo model for evaluating agents that protect against ultraviolet A-induced photoaging. J Invest Dermatol 1998;110:343-347.
165. Kligman L, Akin FJ, Kligman AM. Prevention of ultraviolet damage to the dermis of hairless mice by sunscreens. J Invest Dermatol 1982;78:181-189.
166. Kligman L, Akin FJ, Kligman AM. Sunscreens promote repair of ultraviolet radiation-induced dermal damage. J Invest Dermatol 1983;81:98-102.
167. Levin AA, Sturzenbecker LJ, Kazmer S, Bosakowski T, Huselton C, Allenby G, et al. 9-cis Retinoic acid stereoisomer binds and activates the nuclear receptor RXR alpha. Nature 1992;355:359-361.
168. Kang S, Voorhees JJ. Topical retinoids. In: Freedberg IM, Eisen AZ, Wolff K, Austen F, Goldsmith LA, Katz SI, eds. Fitzpatrick's dermatology in general medicine. New York: McGraw-Hill; 2003. p. 2328-2334.
169. Olsen EA, Katz HI, Levine N, Nigra TP, Pochi PE, Savin RC, et al. Tretinoin emollient cream for photodamaged skin: results of 48-week, multicenter, double-blind studies. J Am Acad Dermatol 1997;37:217-226.
170. Griffiths C, Russman AN, Majmudar G, Singer RS, Hamilton TA, Voorhees JJ. Restoration of collagen formation in photodamaged human skin by tretinoin (retinoic acid). N Engl J Med 1993;329:530-535.
171. Sefton J, Kligman AM, Kopper SC, Lue JC, Gibson JR. Photodamage pilot study: a double-blind, vehicle-controlled study to assess the efficacy and safety of tazarotene 0.1% gel. J Am Acad Dermatol 2000;43:656-663.
172. Colven RM, Pinnell SR. Topical vitamin C in aging. Clin Dermatol 1996;14:227-234.
173. Lin JY, Selim MA, Shea CR, Grichnik JM, Omar MM, Monteiro-Riviere NA, et al. UV photoprotection by combination topical antioxidants vitamin C and vitamin E. J Am Acad Dermatol 2003;48:866-874.
174. Nusgens BV, Humbert P, Rougier A, Colige AC, Haftek M, Lambert CA, et al. Topically applied vitamin C enhances the mRNA level of collagens I and III, their processing enzymes and tissue inhibitor of matrix metalloproteinase 1 in the human dermis. J Invest Dermatol 2001;116:853-859.
175. Greco RJ. Topical vitamin C. Plast Reconstr Surg 2000;105:464-465.
176. Fischer TW, Wigger-Alberti W, Elsner P. Direct and non-direct measurement techniques for analysis of skin surface topography. Skin Pharmacol Appl Skin Physiol 1999;12:1-11.
177. Suzuki YJ, Aggarwal BB, Packer L. Alpha-lipoic acid is a potent inhibitor of NF-kappa B activation in human T cells. Biochem Biophys Res Commun 1992;189:1709-1715.
178. Isnard N, Fodil-Bourahla I, Robert AM, Robert L. Pharmacology of skin aging. Stimulation of glycosaminoglycan biosynthesis by L-fucose and fucose-rich polysaccharides, effect of in vitro aging of fibroblasts. Biomed Pharmacother 2004;58:202-204.
179. Voros E, Robert C, Robert AM. Age-related changes of the human skin surface microrelief. Gerontology 1990;36:276-285.
180. Ghersetich I, Brazzini B, Peris K, Cotellessa C, Manunta T, Lotti T. Pyruvic acid peels for the treatment of photoaging. Dermatol Surg 2004;30:32-36.
181. Kauvar ANB, Dover JS. Facial skin rejuvenation: laser resurfacing or chemical peel: choose your weapon. Dermatol Surg 2001;27:209-212.
182. Brody HJ. Chemical peeling: an updated review. J Cutan Med Surg 1999;3:14-20.
183. Stiller MJ, Bartolone J, Stern R, Smith S, Kollias N, Gillies R, et al. Topical 8% glycolic acid and 8% L-lactic acid creams for the treatment of photodamaged skin. A double-blind vehicle-controlled clinical trial. Arch Dermatol 1996;132:631-636.
184. Kaidbey K, Sutherland B, Bennett P, Wamer WG, Barton C, Dennis D, et al. Topical glycolic acid enhances photodamage by ultraviolet light. Photodermatol Photoimmunol Photomed 2003;19:21-27.
185. Karimipour DJ, Kang S, Johnson TM, Orringer JS, Hamilton T, Hammerberg C, et al. Microdermabrasion: a molecular analysis following a single treatment. J Am Acad Dermatol 2005;52:215-223.
186. Coimbra M, Rohrich RJ, Chao J, Brown SA. A prospective controlled assessment of microdermabrasion for damaged skin and fine rhytides. Plast Reconstr Surg 2004;113:1438-1443.
187. Tanzi EL, Lupton JR, Alster TS. Lasers in dermatology: four decades of progress. J Am Acad Dermatol 2003;49:1-31.
188. Anderson RR, Parrish JA. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983;220:524-527.
189. Apfelberg DB. Ultrapulse carbon dioxide laser with CPG scanner for full-face resurfacing for rhytids, photoaging, and acne scars. Plast Reconstr Surg 1997;99:1817-1825.
190. West TB, Alster TS. Improvement of infraorbital hyperpigmentation following carbon dioxide laser resurfacing. Dermatol Surg 1998;24:615-616.
191. Orringer JS, Kang S, Johnson TM, Karimipour DJ, Hamilton T, Hammerberg C, et al. Connective tissue remodeling induced by carbon dioxide laser resurfacing of photodamaged human skin. Arch Dermatol 2004;140:1326-1332.
192. Kopera D, Smolle J, Kaddu S, Kerl H. Nonablative laser treatment of wrinkles: meeting the objective? Assessment by 25 dermatologists. Br J Dermatol 2004;150:936-939.
193. Zelickson BD, Kist D, Bernstein E, Brown DB, Ksenzenko S, Burns J, et al. Histological and ultrastructural evaluation of the effects of a radiofrequency-based nonablative dermal remodeling device: a pilot study. Arch Dermatol 2004;140:204-209.
194. Fitzpatrick RE, Geronemus R, Goldberg D, Kaminer MS, Kilmer S, Ruiz-Esparza J. Multicenter study of noninvasive radiofrequency for periorbital tissue tightening. Laser Surg Med 2003;33:232-242.
195. Montecucco C, Schiavo G. Tetanus and botulinum neurotoxins: a new group of zinc proteases. Trends Biochem Sci 1993;18:324-327.
196. Vartanian AJ, Dayan SH. Facial rejuvenation using botulinum toxin A: review and updates. Facial Plast Surg 2004;20:11-19.
197. Setler P. The biochemistry of botulinum toxin type B. Neurology 2000;55(Suppl):S23-S28.
198. Donofrio LM. Structural autologous lipoaugmentation: a pan-facial technique. Dermatol Surg 2000;26:1129-1134.
199. Matti BA, Nicolle FV. Clinical use of Zyplast in correction of age- and disease-related contour deficiencies of the face. Aesthetic Plast Surg 1990;14:227-234.
200. Stegman SJ, Chu S, Armstrong R. Adverse reactions to bovine collagen implant: clinical and histologic features. J Dermatol Surg Oncol 1988;14:39-48.
201. Manna F, Dentini M, Desideri P, De Pita O, Mortilla E, Maras B. Comparative chemical evaluation of two commercially available derivatives of hyaluronic acid (hylaform from rooster combs and restylane from streptococcus) used for soft tissue augmentation. J Eur Acad Dermatol Venereol 1999;13:183-192.
202. Larsen NE, Pollak CT, Reiner K, Leshchiner E, Balazas EA. Hylan gel biomaterial: dermal and immunologic compatibility. J Biomed Mater Res 1993;27:1129-1134.
203. Piacquadio D, Jarcho M, Goltz R. Evaluation of hylan b gel as a soft-tissue augmentation implant material. J Am Acad Dermatol 1997;36:544-549.
204. Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg 2003;29:573-587.
205. Kim SY, Kim SJ, Lee JY, Kim WG, Park WS, Sim YC, et al. Protective effects of dietary soy isoflavones against UV-induced skin-aging in hairless mouse model. J Am Coll Nutr 2004;23:157-162.
206. Kang S, Chung JH, Lee JH, Fisher GJ, Wan YS, Duell EA, et al. Topical N-acetyl cysteine and genistein prevent ultraviolet-light-induced signaling that leads to photoaging in human skin in vivo. J Invest Dermatol 2003;120:835-841.
207. Vayalil PK, Mittal A, Hara Y, Elmets CA, Katiyar SK. Green tea polyphenols prevent ultraviolet light-induced oxidative damage and matrix metalloproteinases expression in mouse skin. J Invest Dermatol 2004;122:1480-1487.
208. Dell'Aica I, Dona M, Sartor L, Pezzato E, Garbisa S. (-)Epigallocatechin-3-gallate directly inhibits MT1-MMP activity, leading to accumulation of nonactivated MMP-2 at the cell surface. Lab Invest 2002;82:1685-1693.
209. Rattan S, Clark BFC. Kinetin delays the onset of aging characteristics in human fibroblasts. Biochem Biophys Res Commun 1994;201:665-672.
210. Olsen A, Siboska GE, Clark BFC, Rattan SIS. N(6)-Furfuryladenine, kinetin, protects against Fenton reaction-mediated oxidative damage to DNA. Biochem Biophys Res Commun 1999;265:499-502.
211. Lee EH, Faulhaber D, Hanson KM, Ding W, Peters S, Kodali S, et al. Dietary lutein reduces ultraviolet radiation-induced inflammation and immunosuppression. J Invest Dermatol 2004;122:510-517.
212. Sime S, Reeve VE. Protection from inflammation, immunosuppression and carcinogenesis induced by UV radiation in mice by topical Pycnogenol. Photochem Photobiol 2004;79:193-198.
213. Mitani H, Koshiishi I, Sumita T, Imanari T. Prevention of the photodamage in the hairless mouse dorsal skin by kojic acid as an iron chelator. Eur J Pharmacol 2001;411:169-174.
214. Bissett DL, Chatterjee R, Hannon DP. Photoprotective effect of topical anti-inflammatory agents against ultraviolet radiation-induced chronic skin damage in the hairless mouse. Photodermatol Photoimmunol Photomed 1990;7:153-158.
215. Wilgus TA, Koki AT, Zweifel BS, Kusewitt DF, Rubal PA, Oberyszn TM. Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment. Mol Carcinog 2003;38:49-58.
216. Cauchard JH, Berton A, Godeau G, Hornebeck W, Bellon G. Activation of latent transforming growth factor beta 1 and inhibition of matrix metalloprotease activity by a thrombospondin-like tripeptide linked to elaidic acid. Biochem Pharmacol 2004;67:2013-2022.
217. Cai Q, Wei H. Effect of dietary genistein on antioxidant enzyme activities in SENCAR mice. Nutr Cancer 1996;25:1-7.
218. Wei H, Cai Q, Rahn RO. Inhibition of UV light- and Fenton reaction-induced oxidative DNA damage by the soybean isoflavone genistein. Carcinogenesis 1996;17:73-77.
219. De Vries N, De Flora S. N-acetyl l-cysteine. J Cell Biochem Suppl 1993;(Suppl 17F);270-8.
220. Katiyar SK, Elmets CA. Green tea polyphenolic antioxidants and skin photoprotection. Int J Oncol 2001;18:1307-1313.
221. Niwa Y, Akamatsu H. Kojic acid scavenges free radicals while potentiating leukocyte functions including free radical generation. Inflammation 1991;15:303-315.
222. Garcia A, Fulton JE. The combination of glycolic acid and hydroquinone or kojic acid for the treatment of melasma and related conditions. Dermatol Surg 1996;22:443-447.
223. Bielinska A, Shivdasani RA, Zhang L, Nabel GJ. Regulation of gene expression with double-stranded phosphorothioate. Science 1990;250:997-1000.
|
Language: | English.
|
Document Type: | Continuing Medical Education.
|
Journal Subset: | Clinical Medicine.
|
ISSN: | 0190-9622
|
NLM Journal Code: | hvg, 7907132
|
Annotation(s) | |
|
|